Search Results - "Iannaccone, T."

Refine Results
  1. 1

    Childhood spinal muscular atrophy: controversies and challenges by Mercuri, Eugenio, Prof, Bertini, Enrico, MD, Iannaccone, Susan T, Prof

    Published in Lancet neurology (01-05-2012)
    “…Summary Spinal muscular atrophy is an autosomal recessive disorder characterised by degeneration of motor neurons in the spinal cord and is caused by mutations…”
    Get full text
    Journal Article
  2. 2

    Social Media and Clinical Trials in Pediatric Disease: Musings From the Bench by Nelson, Leslie, Iannaccone, Susan T.

    Published in Frontiers in genetics (04-10-2021)
    “…The use of social media in clinical trials, for recruiting and retention as well as for collecting data, has become increasingly common. However, little has…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder by Kalvakuntla, Sanjana, Lee, MinJae, Chung, Wendy K, Demarest, Scott, Freed, Amber, Horning, Kyle J, Bichell, Terry Jo, Iannaccone, Susan T, Goodspeed, Kimberly

    Published in Frontiers in neuroscience (21-02-2023)
    “…SLC6A1-related disorder is a genetic neurodevelopmental disorder that is caused by loss of function variants in the gene. Solute Carrier Family 6 Member 1 ( )…”
    Get full text
    Journal Article
  6. 6

    Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence by Pezzullo, A M, Ferraro, C, Sellitto, C, Iannaccone, T, Giudice, V, Centola, R, Manzo, V, Salvo, F, Filippelli, A

    Published in Drug safety (01-10-2022)
    “…Introduction: Selective Serotonin Reuptake Inhibitors (SSRI), commonly used for treating depression, have better tolerability and fewer adverse drug-related…”
    Get full text
    Journal Article
  7. 7

    Autonomic Nervous System in the Control of Energy Balance and Body Weight : Personal Contributions by Messina, Giovanni, De Luca, Vincenzo, Viggiano, Andrea, Ascione, A., Iannaccone, T., Chieffi, Sergio, Monda, Marcellino

    Published in Neurology research international (01-01-2013)
    “…The prevalence of obesity is increasing in the industrialized world, so that the World Health Organization considers obesity as a “pandemia” in rich…”
    Get full text
    Journal Article
  8. 8

    Functional Muscle Ischemia in Neuronal Nitric Oxide Synthase-Deficient Skeletal Muscle of Children with Duchenne Muscular Dystrophy by Sander, M, Chavoshan, B, Harris, S A, Iannaccone, S T, Stull, J T, Thomas, G D, Victor, R G

    “…Duchenne muscular dystrophy (DMD) is a fatal disease caused by mutation of the gene encoding the cytoskeletal protein dystrophin. Despite a wealth of recent…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients by MILONE, M, SHEN, X. M, SELCEN, D, OHNO, K, BRENGMAN, J, IANNACCONE, S. T, HARPER, C. M, ENGEL, A. G

    Published in Neurology (21-07-2009)
    “…Pathogenic mutations in rapsyn result in endplate acetylcholine receptor (AChR) deficiency and are a common cause of postsynaptic congenital myasthenic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Congenital Myopathies and Muscular Dystrophies by Gilbreath, Heather R., PA-C, Castro, Diana, MD, Iannaccone, Susan T., MD

    Published in Neurologic clinics (01-08-2014)
    “…The congenital muscular dystrophies (CMD) and myopathies (CM) are a diverse group of diseases that share features such as early onset of symptoms (in the first…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L by Audhya, Ivana F., Szabo, Shelagh M., Bever, Andrea, O’Sullivan, Fiona, Malone, Daniel C., Feeny, David, Neumann, Peter, Iannaccone, Susan T., Jayasinghe, P., Gooch, Katherine L.

    Published in Journal of patient-reported outcomes (15-12-2023)
    “…Background The progression of Duchenne muscular dystrophy (DMD) is characterized by loss of ambulation, respiratory insufficiency, cardiomyopathy, and early…”
    Get full text
    Journal Article
  18. 18

    New results for risdiplam in spinal muscular atrophy by Iannaccone, Susan T

    Published in Lancet neurology (01-12-2022)
    “…Risdiplam was approved by the US Food and Drug Administration (FDA) in 2020 for use to begin at age 2 months in patients with spinal muscular atrophy whose…”
    Get full text
    Journal Article
  19. 19

    Nemaline myopathy: A clinical study of 143 cases by Ryan, Monique M., Schnell, Christina, Strickland, Corinne D., Shield, Lloyd K., Morgan, Graeme, Iannaccone, Susan T., Laing, Nigel G., Beggs, Alan H., North, Kathryn N.

    Published in Annals of neurology (01-09-2001)
    “…We report 143 Australian and North American cases of primary nemaline myopathy. As classified by the European Neuromuscular Centre guidelines, 23 patients had…”
    Get full text
    Journal Article
  20. 20

    Nor-clozapine Plasma Concentration/daily Clozapine Dose Ratio (Ncz/d): an Index of Response to Clozapine Treatment by Prisco, V, Iannaccone, T, Fabrazzo, M

    Published in European psychiatry (28-03-2015)
    “…The present study investigated relationships between plasma concentrations of clozapine (CZ) and nor-clozapine (NCZ), clozapine metabolic index (NCZ/CZ),…”
    Get full text
    Journal Article